我是 LongbridgeAI，我可以總結文章信息。Schall 律師事務所正在調查 Omeros Corporation（納斯達克代碼：OMER）可能違反證券法的情況，特別是關於虛假或誤導性陳述以及未能披露重要信息的情況。此次調查源於 2026 年 6 月 26 日的一份新聞稿，其中歐洲藥品管理局的藥物委員會對 Omeros 的藥物 narsoplimab 發表了負面意見，導致其股價下跌超過 19.1%。遭受損失的投資者被鼓勵聯繫該事務所以討論他們的權利
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Omeros Corporation (“Omeros” or “the Company”) (NASDAQ: OMER) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Omeros issued a press release on June 26, 2026 announcing “an update on the review by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of the company's marketing authorization application (MAA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA)." According to the Company, "following an oral explanation meeting with the CHMP held this week, at which Omeros presented its position together with four international experts in hematopoietic cell transplantation, Omeros was informed that the CHMP has adopted a negative opinion on the MAA for narsoplimab in TA-TMA." Based on this news, shares of Omeros fell by more than 19.1% on the same day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260706077341/en/